Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

849
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
849
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

389
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
389
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

2.6K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.6K
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.2K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.2K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.2K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.2K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

151
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
151

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Large Language Model-Based Agents for Physical Activity and Cognitive Training: Scoping Review.

JMIR AI·2026
Same author

Barriers and strategies for pain management in non-verbal people with dementia in residential care facilities: protocol for an e-Delphi study.

BMJ open·2025
Same author

Pulmonary Rehabilitation Nursing Interventions Promoting Self-Care in Elderly People with Chronic Obstructive Pulmonary Disease (At Home).

Healthcare (Basel, Switzerland)·2025
Same author

The smart home, a true home? How new technologies disrupt the experience of home for older persons.

Universal access in the information society·2025
Same author

Protocol for a usability and pilot implementation study of a digital medical device to assess pain in non-verbal people with dementia in Portuguese residential care facilities.

Digital health·2025
Same author

Sleep-enhancing nursing interventions in hospital wards: A systematic review.

International nursing review·2024

相关实验视频

Updated: Sep 14, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

586

药物使用的对话剂:eCCo数据库的见解

Mara Pereira Guerreiro1,2, Helga Rafael Henriques3, Elena Mugellini4,5

  • 1Nursing Research, Innovation and Development Centre of Lisbon, Nursing School of Lisbon, Lisbon, Portugal. mguerreiro@egasmoniz.edu.pt.

International journal of clinical pharmacy
|July 21, 2025
PubMed
概括

eCCo数据库列出了关于健康中的对话代理人的研究. 大多数关于药物相关药物的研究都侧重于可用性,这表明需要更多的有效性研究.

关键词:
人工智能的人工智能是人工智能.交谈代理人 交谈代理人数字健康数字健康药物治疗的坚持 药物治疗的坚持自主管理的自我管理.虚拟人类是虚拟的人类.

更多相关视频

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

690
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K

相关实验视频

Last Updated: Sep 14, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

586
Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

690
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K

科学领域:

  • 计算机科学 计算机科学
  • 医疗信息学 医疗信息学
  • 人与计算机的交互

背景情况:

  • 交谈代理人模拟人类对话,用于健康和福祉应用.
  • eCCo数据库汇编了有关这些药物的研究,目前列出了1991-2022年间的657篇论文.
  • 其中,51篇论文专门讨论了对话代理人使用药物的问题.

研究的目的:

  • 将eCCo数据库作为研究健康中的对话代理的资源.
  • 突出研究趋势和缺口,特别是在与医学相关的应用方面.
  • 鼓励社区为数据库增强做出贡献.

主要方法:

  • eCCo数据库被系统地编译和分类.
  • 根据论文的重点 (例如可用性,有效性,实施) 分析了论文.
  • 交谈代理人根据实施方案 (非实施方案,虚拟实施方案) 进行分类.

主要成果:

  • 该数据库包含657项关于健康和福祉中的对话代理人的研究.
  • 51项研究重点关注药物的使用,主要强调可用性而不是有效性.
  • 非体现的代理人 (24) 是最常见的,其次是虚拟体现 (19),通常是虚拟人类 (16).

结论:

  • eCCo数据库提供了一个有价值的工具,用于评估医疗保健中的对话代理研究.
  • 目前对与药物相关的对话药物的研究需要更严格地评估其有效性和实施.
  • 未来的努力将集中在2022年以后扩大和完善数据库.